Morcellation During Uterine Tissue Extraction （分碎术中子宫组织提取）.pdfVIP

Morcellation During Uterine Tissue Extraction AAGL Advancing Minimally Invasive Gynecology Worldwide The Tissue Extraction Task Force members had no commercial, proprietary, or financial interest in the products or companies described in the report. On May 6, 2014, the report was approved by members of the AAGL Board of Trustees who have no commercial, proprietary, or financial interest in the products or companies described in the report. Dr. Ceana Nezhat, President of AAGL, voluntarily recused himself from discussion of the Tissue Extraction Task Force report and from any vote related to the report in accordance with the AAGL Conflict of Interest Disclosure and Dissociation Policy for Executive Committee Members. I. Introduction: Minimally Invasive Surgery, most uterine cancer cases preoperatively, rare subtypes of Morcellation and the Scope of the Problem uterine cancer (i.e. sarcomas) may mimic the appearance The benefits of minimally invasive surgery (MIS) of benign myomas on imaging. Second, preoperative for treating a variety of gynecologic conditions are well diagnostic testing may not discriminate between benign documented [1-10]. Nearly half of the estimated 400,000 and malignant conditions in these cases [25,26]. Third, inpatient-based hysterectomies performed annually in morcellator device safety and critical understanding of the United States for benign indications employ these how to mitigate morcellator-associated injury continues to innovative techniques [11]. Thousands more women evolve. However, despite our incomplete understanding benefit from MIS in uterus-sparing procedures such of these iss